on 11 Jun 2024
Last Applicant/ Owned by
Ste 201, Bldg 24, Blk C,218 Sangtian St.
Suzhou, Jiangsu
CN
215000
Serial Number
90981041 filed on 24th Aug 2021
Registration Number
7414310 registered on 11th Jun 2024
Correspondent Address
Suite 4500
Indianapolis, IN 46204
UNITED STATES
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary prepar Read More
Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary preparations for medical and pharmaceutical use, namely, preparations for preventing and treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; diagnostic reagents and diagnostic preparations for medical purposes; chemical reagents used for medical or veterinary purposes; biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; adjuvants for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer; vaccines; a full line of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer
09th Feb 2024
09th Feb 2024
No 90981041
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.01.29 -
Helixes
27.03.05 -
Representations of objects forming letters or numerals, including punctuation
Status Date | Action Taken |
---|---|
11th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
11th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
09th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
09th May 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
09th May 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
09th May 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
08th May 2024 | STATEMENT OF USE PROCESSING COMPLETE |
08th May 2024 | DIVISIONAL PROCESSING COMPLETE |
08th May 2024 | SOU EXTENSION 3 GRANTED |
23rd Apr 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |